SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-256153
Filing Date
2023-10-13
Accepted
2023-10-13 16:54:30
Documents
12
Period of Report
2023-10-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d512775d8k.htm   iXBRL 8-K 29687
  Complete submission text file 0001193125-23-256153.txt   153167

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20231010.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20231010_lab.xml EX-101.LAB 17980
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20231010_pre.xml EX-101.PRE 11254
6 EXTRACTED XBRL INSTANCE DOCUMENT d512775d8k_htm.xml XML 3390
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 231325541
SIC: 2834 Pharmaceutical Preparations